Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7701–7750 of 76387
Effective as of April 9, 2025, the Board of Directors (the “Board”) of Argan (“Argan” or the “Company”) appointed Lisa Larroque Alexander as a member of the Board.
Mr. Jack A. Krause notified the Board of Directors (the “Board”) of The Lovesac Company (the “Company”) of his intent to resign from the Board, effective at the conclusion of the Company’s annual meeting of stockholders on June 10, 2025.
On April 9, 2025, Peloton Interactive, Inc. (the “Company”) announced that Charles Kirol had been appointed as Chief Operating Officer (“COO”) of the Company, effective as of April 14, 2025.
On April 9, 2025, the Company announced that Andrew Rendich will transition from Chief Supply Chain Officer (“CSCO”) of the Company to a non-executive, advisory role effective as of April 11, 2025.
On April 7, 2025, the Board of Directors (the “Board”) of Titan Environmental Solutions, Inc. (the “Company”) appointed Edward J. Borkowski and Edward F. Feighan to serve as directors of Company, effective immediately.
On April 7, 2025, the Board of Directors (the “Board”) of Titan Environmental Solutions, Inc. (the “Company”) appointed Edward J. Borkowski and Edward F. Feighan to serve as directors of Company, effective immediately.
On April 3, 2025, David Wells informed The Trade Desk, Inc. (the “Company”) of his intent to not stand for re-election to the Company’s board of directors
On April 9, 2025, the Board of Directors (the “Board”) of AppLovin Corporation (the “Company”) appointed Maynard Webb to the Board and as a member of the Audit Committee and Nominating and Corporate Governance Committee of the Board.
On April 8, 2025, Edward Oberwager notified the Company that he will not stand for re-election as a member of the Board at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
On April 3, 2025, Mr. Timothy Pohl resigned from the Board of the Company as a Class II director of the Board, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Jeffrey Clarke resigned from the Board of the Company as a Class I director of the Board, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Orestes Fintiklis resigned from the Board of the Company as a Class III director of the Board and from all other positions he holds with the Company and each of its subsidiaries, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Pradeep Udhas resigned from the Board of the Company as a Class II director of the Board, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Neal Goldman resigned from the Board of the Company as a Class III director of the Board, effective upon the closing of the Sale Transaction.
On April 3, 2025, Ms. Mona Aboelnaga Kanaan resigned from the Board of the Company as a Class II director of the Board, effective upon the closing of the Sale Transaction.
On April 3, 2025, Ms. Noor Sweid resigned from the Board of the Company as a Class I director of the Board, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Jesus Portillo resigned from the Board of the Company as a Class II director of the Board and from all other positions he holds with the Company and each of its subsidiaries, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Prasad Gundumogula resigned from the Board of Directors (the “ Board ”) of the Company as a Class III director of the Board and from all other positions he holds with the Company and each of its subsidiaries, effective upon the closing of the Sale Transaction.
On April 3, 2025, Mr. Asi Ginio resigned from the Board of the Company as a Class I director of the Board, effective upon the closing of the Sale Transaction.
Ms. Madden will transition to the newly-created position of Senior Vice President, Portfolio Transformation and Senior Advisor.
Ms. Su Ping Lu, age 49, will succeed Ms. Anne T. Madden, age 60, as Senior Vice President and General Counsel
the appointment of Todd Yoder as the Company’s Executive Vice President, Chief Financial Officer and Treasurer, effective April 14, 2025.
Amanda Mobley will step down from her role as the Company’s Interim Chief Financial Officer and has been appointed to Chief Accounting Officer.
Effective May 1, 2025, Craig Colby, the Company’s co-founder, will transition from his current role as the Company’s president to the role of chief success officer
the Board appointed Ken Hohenstein as an 'executive officer' of the Company as defined in Rule 3b-7 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as an 'officer' of the Company as defined in Rule 16a-1(f) of the Exchange Act for purposes of Section 16 of the Exchange Act, effective May 1, 2025.
and Thomas Shea, the Company’s co-founder, chief executive officer and chairman of the Board, will assume the role of president.
On March 21, 2025, Jessica Buss notified Argo Group International Holdings, Inc. (the “Company”) of her resignation as Chief Executive Officer of the Company, effective immediately.
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Stephen Barnes, Rob Cavanaugh, and Richard Eskew, each of whom was an officer of the Company as of immediately prior to the Effective Time, ceased to be an officer of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Stephen Barnes, Rob Cavanaugh, and Richard Eskew, each of whom was an officer of the Company as of immediately prior to the Effective Time, ceased to be an officer of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Stephen Barnes, Rob Cavanaugh, and Richard Eskew, each of whom was an officer of the Company as of immediately prior to the Effective Time, ceased to be an officer of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Stephen Barnes, Rob Cavanaugh, and Richard Eskew, each of whom was an officer of the Company as of immediately prior to the Effective Time, ceased to be an officer of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
At the Effective Time, pursuant to the Merger Agreement, Rajeev Singh, Jeff Brodsky, Michael Hilton, Jeff Jordan, Cindy Kent, Peter Klein, Dawn Lepore, Elizabeth Nabel, and Pat Wadors, each of whom was a director of the Company as of immediately prior to the Effective Time, ceased to be a director of the Company
On April 7, 2025, the Board of Directors of the Company also determined that Thomas F. Cowhey, currently the Executive Vice President and Chief Financial Officer of CVS Health, will cease to serve as Executive Vice President and Chief Financial Officer of CVS Health as of the Effective Date.
On April 7, 2025, the Board of Directors of CVS Health Corporation (the “Company” or “CVS Health”) appointed Brian O. Newman to serve as Executive Vice President and Chief Financial Officer of CVS Health, effective May 12, 2025 (the “Effective Date”).
Kenneth E. Ludlum has agreed to resign and has submitted his resignation to the Company’s Board and all committees thereof, effective as of April 7, 2025.
On April 7, 2025, Khaled Al Mogharbel indicated that he will step down as Executive Vice President, Geographies, of Schlumberger Limited (“SLB”), effective as of May 1, 2025, after a distinguished 30-year career with SLB.
On April 2, 2025, Chimera Investment Corporation (the “Company”) and Dan Thakkar mutually agreed that Mr. Thakkar will step down from his position as the Company’s Chief Credit & Risk Officer, effective July 1, 2025
On April 7, 2025, Newmark Group, Inc. (the “Company” or “Newmark”) appointed Luis Alvarado to serve as Chief Operating Officer of the Company.
Effective April 2, 2025, David B. Fountain’s tenure as TVA’s Executive Vice President, General Counsel and Corporate Secretary ended.
On April 4, 2025, HireQuest, Inc. (the "Company") appointed, effective May 31, 2025, C. David Hartley to serve as Chief Financial Officer.
Steve Crane, the Company's Chief Financial Officer, informed the Company of his intention to retire from his role effective May 31, 2025.
On April 8, 2025, Mr. Earl Collier, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), informed the Board he will not stand for re-election to the Board following the Annual Meeting of Shareholders which is scheduled to occur on May 22, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.